+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Continuous Subcutaneous Insulin Infusion Market by Product Type, Insulin Type, Distribution Channel, End User, Age Group - Global Forecast to 2030- Product Image
Continuous Subcutaneous Insulin Infusion Market by Product Type, Insulin Type, Distribution Channel, End User, Age Group - Global Forecast to 2030- Product Image
Sale

Continuous Subcutaneous Insulin Infusion Market by Product Type, Insulin Type, Distribution Channel, End User, Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337448
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The continuous subcutaneous insulin infusion market is rapidly evolving, propelled by breakthroughs in digital health, device connectivity, and patient-centric therapy. Senior decision-makers must navigate a complex competitive landscape shaped by regulatory, technological, and reimbursement shifts.

Market Snapshot: Continuous Subcutaneous Insulin Infusion Market

The continuous subcutaneous insulin infusion market grew from USD 3.05 billion in 2024 to USD 3.43 billion in 2025. It is expected to continue at a CAGR of 12.20%, reaching USD 6.09 billion by 2030. Market expansion is driven by increased adoption of programmable insulin delivery devices, tighter glycemic management requirements, and healthcare systems prioritizing outcomes-based diabetes solutions.

Scope & Segmentation

  • Product Types: Conventional pumps (electronics based, mechanical) and patch pumps, each targeting unique user needs regarding precision dosing and minimal device footprint.
  • Insulin Types: Rapid acting analogs, regular insulin, and short-acting options, supporting diverse clinical requirements.
  • Distribution Channels: Hospital pharmacies (inpatient, outpatient), online channels (manufacturer websites, third party platforms), and retail pharmacies, enabling optimized patient access.
  • End Users: Ambulatory care settings (diabetes and general clinics), homecare, private hospitals, and public hospitals, reflecting broad adoption scenarios.
  • Age Groups: Adult, geriatric, and pediatric populations, driving differentiation in design and support.
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, and additional key markets).
  • Technologies: Integrated continuous glucose monitoring, closed-loop systems, algorithmic insulin dosing, wireless connectivity, and advances in sensor integration and durable device materials.
  • Leading Companies: Medtronic plc, Insulet Corporation, Tandem Diabetes Care, Roche Diabetes Care AG, Ypsomed AG, Sooil Development, Medtrum Technologies, and Bigfoot Biomedical.

Key Takeaways for Decision-Makers

  • Adoption momentum is shifting toward devices offering automated dosing, cybersecurity, and enhanced usability to align with both clinical and operational demands.
  • Market access is affected by evolving reimbursement models rewarding outcome performance and long-term reductions in diabetes-related complications.
  • Integrated glucose monitoring and digital health platforms are strengthening therapy personalization and extending remote patient support.
  • Segmented product offerings enable targeting of varied user needs in ambulatory, home, and hospital environments, increasing relevance across age groups.
  • Collaboration between manufacturers, advocacy groups, and healthcare systems is accelerating access, innovation, and adherence to regulatory standards.
  • Market leaders continually invest in platform enhancement and interoperability to maintain resilience and market positioning in a shifting environment.

Tariff Impact on Insulin Infusion Devices

Recent policy changes in the United States introduced tariffs on imported components essential for continuous subcutaneous insulin infusion systems. The resulting cost pressures are influencing manufacturers to reconsider sourcing strategies and invest in local assembly. These dynamics are also prompting engagement with regulators about potential exemptions and driving exploration of alternative procurement and distribution models to secure uninterrupted supply and sustainable pricing.

Methodology & Data Sources

This analysis integrates comprehensive secondary research—including regulatory filings, company reports, and peer-reviewed literature—with rigorous primary validation via interviews with clinical and industry experts. Cross-referencing of regional policy trends, usage data, and expert perspectives ensures interpretation accuracy.

Why This Report Matters

  • Informs strategic planning by distilling actionable insights on technology adoption, regulatory compliance, and reimbursement changes in the insulin infusion landscape.
  • Supports decision-making with a clear view of competitive movements, supply chain risk, and partnership opportunities across global markets.
  • Guides investment by providing up-to-date segmentation and market trends, positioning stakeholders for effective resource allocation and scalable growth.

Conclusion

This report offers clear guidance on navigating the continuous subcutaneous insulin infusion market’s evolving demands. Informed decision-making will enable stakeholders to align innovation, compliance, and access strategies for long-term success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Continuous Subcutaneous Insulin Infusion Market, by Product Type
8.1. Introduction
8.2. Conventional
8.2.1. Electronics Based Pumps
8.2.2. Mechanical Pumps
8.3. Patch
9. Continuous Subcutaneous Insulin Infusion Market, by Insulin Type
9.1. Introduction
9.2. Rapid Acting Analog
9.3. Regular Insulin
9.4. Short Acting
10. Continuous Subcutaneous Insulin Infusion Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.2.1. Inpatient Pharmacies
10.2.2. Outpatient Pharmacies
10.3. Online Pharmacies
10.3.1. Manufacturer Websites
10.3.2. Third Party Platforms
10.4. Retail Pharmacies
11. Continuous Subcutaneous Insulin Infusion Market, by End User
11.1. Introduction
11.2. Ambulatory Care
11.2.1. Diabetes Clinics
11.2.2. General Clinics
11.3. Homecare
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
12. Continuous Subcutaneous Insulin Infusion Market, by Age Group
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric
13. Americas Continuous Subcutaneous Insulin Infusion Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Continuous Subcutaneous Insulin Infusion Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Continuous Subcutaneous Insulin Infusion Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Medtronic plc
16.3.2. Insulet Corporation
16.3.3. Tandem Diabetes Care, Inc.
16.3.4. Roche Diabetes Care AG
16.3.5. Ypsomed AG
16.3.6. Sooil Development Co., Ltd.
16.3.7. Medtrum Technologies, Inc.
16.3.8. Bigfoot Biomedical, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET MULTI-CURRENCY
FIGURE 2. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET MULTI-LANGUAGE
FIGURE 3. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ELECTRONICS BASED PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY MECHANICAL PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RAPID ACTING ANALOG, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGULAR INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SHORT ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INPATIENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY OUTPATIENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 64. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 65. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 67. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 68. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 70. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 71. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 72. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 74. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 77. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 78. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 80. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 81. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 123. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 125. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 128. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 129. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 131. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 132. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 133. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 135. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 136. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 138. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 139. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 141. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 142. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 153. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 155. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 156. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 158. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 159. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 161. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 162. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 163. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 165. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 166. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 168. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 169. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 171. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 172. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 203. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 205. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 206. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 208. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 209. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 211. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 212. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 223. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 225. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 226. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 228. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 229. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 231. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 232. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 233. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 235. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 236. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 238. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 239. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 241. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 242. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 243. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 245. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 253. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 255. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 256. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 263. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 264. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 265. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 266. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 268. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 269. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 271. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 272. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 273. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 275. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 276. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 278. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 279. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUS

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Continuous Subcutaneous Insulin Infusion market report include:
  • Medtronic plc
  • Insulet Corporation
  • Tandem Diabetes Care, Inc.
  • Roche Diabetes Care AG
  • Ypsomed AG
  • Sooil Development Co., Ltd.
  • Medtrum Technologies, Inc.
  • Bigfoot Biomedical, Inc.

Table Information

Report AttributeDetails
No. of Pages187
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.43 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.09 Billion
Compound Annual Growth Rate12.2%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Continuous Subcutaneous Insulin Infusion Market Size, Share & Trends Analysis Report By Product, By Patient Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Continuous Subcutaneous Insulin Infusion Market Size, Share & Trends Analysis Report By Product, By Patient Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 110 Pages
  • Global
From
Insulin Patch Pumps Market Report 2025 - Product Image

Insulin Patch Pumps Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Insulin Pumps & Continuous Glucose Monitors Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036 - Product Image

Insulin Pumps & Continuous Glucose Monitors Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036

  • Report
  • 52 Pages
  • Global
From
Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Image

Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • 216 Pages
  • Global
From
Smart Insulin Pens and Pumps - Global Strategic Business Report - Product Image

Smart Insulin Pens and Pumps - Global Strategic Business Report

  • Report
  • 131 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.